Molecular genetic analysis and phenotypic characteristics of a consanguineous family with glycogen storage disease type Ia

Lu,Yili; Wang,Liyin; Li,Jun; Wu,Beibei; Wu,Huiping; Luo,Yue; Jin,Zi‑Bing; Shan,Xiaoou

doi:10.3892/mmr.2016.5617

Molecular genetic analysis and phenotypic characteristics of a consanguineous family with glycogen storage disease type Ia

Authors:
- Yili Lu
- Liyin Wang
- Jun Li
- Beibei Wu
- Huiping Wu
- Yue Luo
- Zi‑Bing Jin
- Xiaoou Shan
View Affiliations

Affiliations: Department of Pediatrics, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325027, P.R. China, College of Basic Medical Sciences, Capital Medical University, Beijing 100069, P.R. China, Department of Hand Surgery, Wenzhou Donghua Hospital, Wenzhou, Zhejiang 325027, P.R. China, Division of Ophthalmic Genetics, Laboratory for Stem Cell and Retinal Regeneration, The Eye Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325027, P.R. China
Published online on: August 9, 2016 https://doi.org/10.3892/mmr.2016.5617
Pages: 3251-3254

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Glycogen storage disease type‑Ia (GSD‑Ia) is a rare autosomal recessive disease caused by a mutation in the gene encoding glucose‑6‑phosphate‑α (G6PC). The present study reported the case of a 3‑month‑old female Chinese patient with GSD‑Ia born to consanguineous parents. The aim of the present study was to identify the precise mutation of the G6PC gene associated with this family and to describe the phenotypic characteristics of the patient. A comprehensive examination was performed on the patient, including physical examination, vein blood gas analysis, abdominal sonography and biochemical analyses. In addition, gene sequencing was performed on the coding region of the G6PC gene to identify the mutation. The patient was diagnosed with GSD‑Ia and a G6PC missense mutation of c.518T>C (p.L173P) located in a highly conserved area was identified. The mutation is in a non‑helical region of the protein, which previous studies have suggested should result in a lesser effect on G6PC enzymatic activity and milder phenotypic characteristics compared with mutations located in helical regions. However, the severity of the disease phenotype in the subject of the present study was inconsistent with that predicted from her genotype. The patient suffered from serious hypoglycemia, lactic acidosis, increased triglycerides, hepatic dysfunction, clear hepatomegaly and nephromegaly. The incidence of the p.L173P mutation may be relatively high in the Chinese population. Knowledge of the various phenotypic presentations of the p.L173P mutation may beneficial for future investigations.

View Figures

View References

1	Moses SW: Historical highlights and unsolved problems in glycogen storage disease type 1. Eur J Pediatr. 161(Suppl 1): S2–S9. 2002. View Article : Google Scholar : PubMed/NCBI
2	Koeberl DD, Kishnani PS, Bali D and Chen YT: Emerging therapies for glycogen storage disease type I. Trends Endocrinol Metab. 20:252–258. 2009. View Article : Google Scholar : PubMed/NCBI
3	Hutton JC and O'Brien RM: Glucose-6-phosphatase catalytic subunit gene family. J Biol Chem. 284:29241–29245. 2009. View Article : Google Scholar : PubMed/NCBI
4	Gu LL, Li XH, Han Y, Zhang DH, Gong QM and Zhang XX: A novel homozygous no-stop mutation in G6PC gene from a Chinese patient with glycogen storage disease type Ia. Gene. 536:362–365. 2014. View Article : Google Scholar
5	Resaz R, Vanni C, Segalerba D, Sementa AR, Mastracci L, Grillo F, Murgia D, Bosco MC, Chou JY, Barbieri O, et al: Development of hepatocellular adenomas and carcinomas in mice with liver-specific G6Pase-α deficiency. Dis Model Mech. 7:1083–1091. 2014. View Article : Google Scholar : PubMed/NCBI
6	Kishnani PS, Austin SL, Abdenur JE, Arn P, Bali DS, Boney A, Chung WK, Dagli AI, Dale D, Koeberl D, et al: Diagnosis and management of glycogen storage disease type I: A practice guideline of the American college of medical genetics and genomics. Genet Med. 16:e12014.PubMed/NCBI
7	Wang J, Cui H, Lee NC, Hwu WL, Chien YH, Craigen WJ, Wong LJ and Zhang VW: Clinical application of massively parallel sequencing in the molecular diagnosis of glycogen storage diseases of genetically heterogeneous origin. Genet Med. 15:106–114. 2013. View Article : Google Scholar
8	Chou JY and Mansfield BC: Mutations in the glucose-6-phosphatase-alpha (G6PC) gene that cause type Ia glycogen storage disease. Hum Mutat. 29:921–930. 2008. View Article : Google Scholar : PubMed/NCBI
9	Shieh JJ, Terzioglu M, Hiraiwa H, Marsh J, Pan CJ, Chen LY and Chou JY: The molecular basis of glycogen storage disease type 1a: Structure and function analysis of mutations in glucose-6-phosphatase. J Biol Chem. 277:5047–5053. 2002. View Article : Google Scholar
10	Chou JY, Jun HS and Mansfield BC: Glycogen storage disease type I and G6Pase-β deficiency: Etiology and therapy. Nat Rev Endocrinol. 6:676–688. 2010. View Article : Google Scholar : PubMed/NCBI
11	Li DZ, Liao C and Tang XW: Prenatal diagnosis of glycogen storage disease type Ia, presenting a new mutation in the glucose-6-phosphatase gene. Prenat Diagn. 27:685–686. 2007. View Article : Google Scholar : PubMed/NCBI
12	Shah KK and O'Dell SD: Effect of dietary interventions in the maintenance of normoglycaemia in glycogen storage disease type 1a: A systematic review and meta-analysis. J Hum Nutr Diet. 26:329–339. 2013. View Article : Google Scholar : PubMed/NCBI
13	Belingheri M, Ghio L, Sala A, Menni F, Trespidi L, Ferraresso M, Berardinelli L, Rossi G, Edefonti A and Parini R: Combined liver-kidney transplantation in glycogen storage disease Ia: A case beyond the guidelines. Liver Transpl. 13:762–764. 2007. View Article : Google Scholar : PubMed/NCBI
14	Marega A, Fregonese C, Tulissi P, Vallone C, Gropuzzo M, Toniutto PL, Baccarani U, Bresadola F, Toso F and Montanaro D: Preemptive liver-kidney transplantation in von Gierke disease: A case report. Transplant Proc. 43:1196–1197. 2011. View Article : Google Scholar : PubMed/NCBI
15	Yiu WH, Lee YM, Peng WT, Pan CJ, Mead PA, Mansfield BC and Chou JY: Complete normalization of hepatic G6PC deficiency in murine glycogen storage disease type Ia using gene therapy. Mol Ther. 18:1076–1084. 2010. View Article : Google Scholar : PubMed/NCBI
16	Lee YM, Jun HS, Pan CJ, Lin SR, Wilson LH, Mansfield BC and Chou JY: Prevention of hepatocellular adenoma and correction of metabolic abnormalities in murine glycogen storage disease type Ia by gene therapy. Hepatology. 56:1719–1729. 2012. View Article : Google Scholar : PubMed/NCBI
17	Lee YM, Pan CJ, Koeberl DD, Mansfield BC and Chou JY: The upstream enhancer elements of the G6PC promoter are critical for optimal G6PC expression in murine glycogen storage disease type Ia. Mol Genet Metab. 110:275–280. 2013. View Article : Google Scholar : PubMed/NCBI
18	Clar J, Mutel E, Gri B, Creneguy A, Stefanutti A, Gaillard S, Ferry N, Beuf O, Mithieux G, Nguyen TH and Rajas F: Hepatic lentiviral gene transfer prevents the long-term onset of hepatic tumours of glycogen storage disease type 1a in mice. Hum Mol Genet. 24:2287–2296. 2015. View Article : Google Scholar : PubMed/NCBI
19	Resaz R, Emionite L, Vanni C, Astigiano S, Puppo M, Lavieri R, Segalerba D, Pezzolo A, Bosco MC, Oberto A, et al: Treatment of newborn G6pc(-/-) mice with bone marrow-derived myelomonocytes induces liver repair. J Hepatol. 55:1263–1271. 2011. View Article : Google Scholar : PubMed/NCBI